Literature DB >> 11086207

The inherited nature of lung cancer: a pilot study.

M E Wood1, K Kelly, L G Mullineaux, P A Bunn.   

Abstract

The role of both primary and secondary cigarette smoke exposure in the causation of lung cancer appears certain. An estimated 90% of lung cancer is attributed to cigarette smoke. Remarkably, however, less then 20% of cigarette smokers develop lung cancer. Investigators have suggested that a genetic predisposition to lung cancer may contribute to familial aggregation of this cancer. To understand the contribution of familial aggregation to this type of cancer and potentially identify individuals and families, which may be important in identifying gene(s) responsible for lung cancer, we developed criteria for identification of high-risk families. We have tested the feasibility and utility of these criteria at three Denver, CO hospitals with very different patient populations. Four hundred eighteen individuals were diagnosed with lung cancer at these three hospitals between 1/1/95 and 8/31/95. Twenty-nine percent of individuals expired prior to the time of initial contact. Family history data were obtained on 182 individuals. To be considered positive (suggesting possible autosomal dominant inheritance of lung cancer), families must have at least two first-degree relatives with lung cancer, one of which must be diagnosed before the age of 55. Seventeen of 182 (9.3%) families in the study population met these criteria. We reviewed the remaining family histories that did not meet the established criteria and identified another 2.3% (5/182) of families had evidence for autosomal dominant transmission of lung cancer. An additional 15% (23/182) of families had histories which could not be classified without further information. This study suggests that at least 11.6% of individuals diagnosed with lung cancer will have a positive family history of lung cancer. Use of the criteria developed for this study may lead to an underestimation of the inherited etiology of lung cancer.

Entities:  

Mesh:

Year:  2000        PMID: 11086207     DOI: 10.1016/s0169-5002(00)00142-2

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

1.  Complex segregation analysis reveals a multigene model for lung cancer.

Authors:  Hongyan Xu; Margaret R Spitz; Christopher I Amos; Sanjay Shete
Journal:  Hum Genet       Date:  2004-11-16       Impact factor: 4.132

2.  Mechanisms of differential expression of the CYP2A13 7520C and 7520G alleles in human lung: allelic expression analysis for CYP2A13 heterogeneous nuclear RNA, and evidence for the involvement of multiple cis-regulatory single nucleotide polymorphisms.

Authors:  Hong Wu; Xiuling Zhang; Guoyu Ling; Jaime D'Agostino; Xinxin Ding
Journal:  Pharmacogenet Genomics       Date:  2009-11       Impact factor: 2.089

3.  The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients.

Authors:  Moo Suk Park; Yoon Soo Chang; Ju Hye Shin; Dae Joon Kim; Kyung Young Chung; Dong Hwan Shin; Jin Wook Moon; Shin Myung Kang; Chang Hoon Hahn; Young Sam Kim; Joon Chang; Sung Kyu Kim; Se Kyu Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

4.  Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.

Authors:  Govinda Lenka; Mong-Hsun Tsai; Hsin-Chieh Lin; Jen-Hao Hsiao; Yi-Ching Lee; Tzu-Pin Lu; Jang-Ming Lee; Chung-Ping Hsu; Liang-Chuan Lai; Eric Y Chuang
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

5.  Integrative Bioinformatics Analysis Reveals Potential Long Non-Coding RNA Biomarkers and Analysis of Function in Non-Smoking Females with Lung Cancer.

Authors:  Fang Qiao; Na Li; Wei Li
Journal:  Med Sci Monit       Date:  2018-08-18

6.  Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.

Authors:  Chuantao Zhang; Man Jiang; Na Zhou; Helei Hou; Tianjun Li; Hongsheng Yu; Yuan-De Tan; Xiaochun Zhang
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

7.  Association of epidermal growth factor receptor and K-Ras mutations with smoking history in non-small cell lung cancer patients.

Authors:  Onur Baykara; Merve Tansarikaya; Ahmet Demirkaya; Kamil Kaynak; Serhan Tanju; Alper Toker; Nur Buyru
Journal:  Exp Ther Med       Date:  2012-11-23       Impact factor: 2.447

8.  SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.

Authors:  Liang-Chuan Lai; Mong-Hsun Tsai; Pei-Chun Chen; Lee H Chen; Jen-Hao Hsiao; Shin-Kuang Chen; Tzu-Pin Lu; Jang-Ming Lee; Chung-Ping Hsu; Chuhsing K Hsiao; Eric Y Chuang
Journal:  J Biomed Sci       Date:  2014-03-21       Impact factor: 8.410

9.  Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses.

Authors:  Guangda Yang; Qianya Chen; Jieming Xiao; Hailiang Zhang; Zhichao Wang; Xiangan Lin
Journal:  Cancer Manag Res       Date:  2018-10-08       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.